Spotlight
Specialty
Partners
CME/CE
An Overview of Graft vs Host Disease (GvHD)
Expert oncologists define graft vs host disease (GvHD) and discuss which risk factors might increase a patient’s risk of developing GvHD.
Now Viewing
EP: 1.An Overview of Graft vs Host Disease (GvHD)
EP: 2.Regimens Used for GvHD Prevention
EP: 3.Clinical Implications of the Phase III BMT CTN 1703 Trial
EP: 4.Future of Acute GvHD Prevention
EP: 5.Acute GvHD: Clinical Presentation, Risk Factors and Treatment Options
EP: 6.Steroid Refractory Acute GvHD and REACH Trials
EP: 7.Novel Agents in Acute GvHD
EP: 8.Defining Chronic Graft vs Host Disease (GvHD)
Related Videos
Related Content
Magrolimab Plus Rituximab/Chemo Elicits Deep Responses in Relapsed/Refractory DLBCL
January 28th 2023
Magrolimab Plus Rituximab/Chemo Elicits Deep Responses in Relapsed/Refractory DLBCL
January 28th 2023
